The medical benefit of 5-HT research

被引:183
作者
Jones, BJ
Blackburn, TP
机构
[1] GlaxoSmithKline, Psychiat Res Dept, Harlow CM19 5AW, Essex, England
[2] Synap Pharmaceut Corp, Paramus, NJ 07652 USA
关键词
5-HT reuptake inhibitors; 5-HT receptor antagonists; 5-HT receptor agonists; therapeutic applications;
D O I
10.1016/S0091-3057(01)00745-6
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
5-HT research is now more than 50 years old. and it has generated a wealth of therapeutic agents, some of which have had a major impact on disease management, The 5-HT reuptake inhibitors (SSRIs) are among the most widely prescribed drugs for treating depression and a variety of other disorders including anxiety, social phobia and premenstrual dysphoria (PMD). The other major success stories of 5-HT research are the discovery of 5-HT1B/D receptor agonists for treating migraine and 5-HT3 receptor antagonists for chemotherapy and radiation-induced emesis. The role of 5-HT in the mechanism of action of antipsychotic agents remains a topic of intense research, which promises better treatments for schizophrenia in the future. Compounds interacting with 5-HT1F, 5-HT2C, 5-HT6 and 5-HT7 receptors are currently under investigation and may prove to have important therapeutic applications in the future. (C) 2002 Published by Elsevier Science Inc.
引用
收藏
页码:555 / 568
页数:14
相关论文
共 154 条
[1]   Serotonin model of schizophrenia: emerging role of glutamate mechanisms [J].
Aghajanian, GK ;
Marek, GJ .
BRAIN RESEARCH REVIEWS, 2000, 31 (2-3) :302-312
[2]  
ALHAIDER AA, 1991, J NEUROSCI, V11, P1881
[3]   THE HYPERSEROTONEMIA OF AUTISM [J].
ANDERSON, GM ;
HORNE, WC ;
CHATTERJEE, D ;
COHEN, DJ .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 600 :331-342
[4]  
Andrews P.L.R, 1994, 5 HYDROXYTRYPTAMINES, P255
[5]  
[Anonymous], DEPRESSION, DOI DOI 10.1002/depr.3050020208
[6]   Buspirone: Future directions [J].
Apter, JT ;
Allen, LA .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (01) :86-93
[7]  
ARTIGAS F, 1994, ARCH GEN PSYCHIAT, V51, P248
[8]   How does pindolol improve antidepressant action? [J].
Artigas, F ;
Celada, P ;
Laruelle, M ;
Adell, A .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (05) :224-228
[9]  
ASBERG M, 1976, ARCH GEN PSYCHIAT, V33, P1193
[10]  
AZMITIA EC, 1991, J CLIN PSYCHIAT, V52, P4